CYP19A1 and polycystic ovary syndrome: Consequently, Fedeli et al. (121) found that at this ratio, MYO and DCI reduced serum DHEA levels in PCOS mice by modulating androgen enzyme expression and increasing CYP19A1 and FSHR synthesis.